Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Irvine, California 92697


Purpose:

RATIONALE: Telephone counseling after treatment may reduce stress and improve the well-being and quality of life of patients who have cervical cancer. Changes in quality of life may be related to changes in immune function and neuroendocrine function. PURPOSE: This randomized phase I trial is studying how well telephone counseling works compared to standard care in reducing stress in patients who have completed treatment for stage I, stage II, or stage III cervical cancer.


Study summary:

OBJECTIVES: - Compare quality of life (QOL) at baseline and changes in QOL, immune response, and neuroendocrine parameters over time in patients who have completed treatment for stage I-III cervical cancer receiving psychosocial telephone counseling vs usual care. - Correlate psychosocial measures with immunologic stance. OUTLINE: This is a randomized, controlled, parallel-group study. Patients are randomized to 1 of 2 intervention arms. - Arm I: Patients undergo psychosocial telephone counseling comprising 5 weekly sessions and a 1-month follow-up session to learn strategies for reducing stress. - Arm II: Patients undergo usual care for approximately 4 months. All patients complete questionnaires and Quality of life assessment at baseline and at 4 months. They also undergo saliva and blood sample collections at baseline and at 4 months for neuroimmune studies. PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.


Criteria:

DISEASE CHARACTERISTICS: - Diagnosis of cervical cancer between the past 3-15 months - Stage I-III disease - Completed therapy for cervical cancer ≥ 1 month ago - Not receiving ongoing treatment PATIENT CHARACTERISTICS: - Resident of Orange, San Diego, or Imperial County in California - English or Spanish speaking - No serious acute or chronic illness - Has access to a telephone PRIOR CONCURRENT THERAPY: - See Disease Characteristics - More than 4 weeks since prior immunotherapy - More than 30 days since prior investigational drugs - No prior biological response modifier - No concurrent corticosteroids - No concurrent immunosuppressive therapy


NCT ID:

NCT00086242


Primary Contact:

Principal Investigator
Lari B. Wenzel, PhD
Chao Family Comprehensive Cancer Center


Backup Contact:

N/A


Location Contact:

Irvine, California 92697
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 12, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.